Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
600 participants
OBSERVATIONAL
2024-08-07
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational Group
This observational (i.e., non-interventional), post-market, real-world, Registry was designed to collect, analyze, and identify relevant safety and performance outcomes for "all comers" using Kerecis devices in routine medical practice within a wide variety of United States (US) medical practice settings.
Kerecis Fish Skin Graft
Patients already treated with a Kerecis device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kerecis Fish Skin Graft
Patients already treated with a Kerecis device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has at least one target wound treated with a Kerecis device according to physician medical judgement within one calendar month prior to the registry enrollment date
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kerecis Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Swearingen
Role: PRINCIPAL_INVESTIGATOR
Kerecis Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MCR Health
Sarasota, Florida, United States
University Park
Sarasota, Florida, United States
Cone Health Ortho Care Greensboro
Greensboro, North Carolina, United States
Feet First Institute of Beavercreek
Beavercreek, Ohio, United States
ABC Podiatry
Columbus, Ohio, United States
South Texas Skin Cancer Center
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KS-1000
Identifier Type: -
Identifier Source: org_study_id